Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000.

@article{Tseng2007SeroprevalenceOH,
  title={Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000.},
  author={F Tseng and T. O'Brien and Mingdong Zhang and Alex H Kral and Betty A. Ortiz-Conde and Jennifer Lorvick and Michael P. Busch and Brian R. Edlin},
  journal={Hepatology},
  year={2007},
  volume={46 3},
  pages={666-71}
}
UNLABELLED Previous studies suggest that most injection drug users (IDUs) become infected with hepatitis C virus (HCV) and hepatitis B virus (HBV) soon after initiating drug use. The Urban Health Study (UHS) recruited serial cross-sections of IDUs in the San Francisco Bay area from 1986 to 2005. In the current study, we determined the prevalence of antibody to HCV and HBV (core) among UHS participants during 1998 to 2000. To examine whether the time from onset of injection to acquisition of… CONTINUE READING
25 Citations
25 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

What is the evidence for the effectiveness of interventions to reduce hepatitis C infection and the associated morbidity? A Health Evidence Network Report

  • NM Wright, CE Millson, CN. Tompkins
  • Copenhagen: WHO,
  • 2005

Hepatitis C prevention and treatment for substance users in the United States: acknowledging the elephant in the living room

  • BR Edlin
  • Int J Drug Policy 2004;15:81-91
  • 2004

Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City

  • T Diaz, DC Des Jarlais, D Vlahov
  • Am J Public Health 2001;912330
  • 2001

Similar Papers

Loading similar papers…